Therapeutic effect of endovenous laser ablation combined with percutaneous continuous circumsuture on severe great saphena varicose
10.11958/20170551
- VernacularTitle:腔内激光闭合术联合皮下环缝术治疗重度大隐静脉曲张的疗效观察
- Author:
qiang Guo TAO
1
;
hua Ming CAO
;
Bin ZHANG
;
fei Yun SI
;
xiang Bing LOU
;
Qi HAN
;
kuan Jia WANG
Author Information
1. 上海市浦东新区浦南医院普外科 200125
- Keywords:
great saphena varicose;
endovenous laser ablation;
percutaneous continuous circumsuture
- From:
Tianjin Medical Journal
2017;45(10):1040-1043
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the therapeutic effects of endovenous laser ablation (EVLA) combined with percutaneous continuous circumsuture (PCCS) and EVLA in treating severe great saphena varicose. Methods A total of 60 patients with unilateral great saphenous varicose level C5-C6 were randomly divided into control group and experimental group according to the CEAP system. Control group was given EVLA surgery while experimental group was given EVLA+PCCS surgery. Data of operation time, hospital stay, intraoperative blood loss, the rate of ulcer healing, variceal recurrence rate and postoperative complication rate within 6 months after operation were compared between two groups. Results The mean operative time and intraoperative blood loss were lower in the experimental group than those in the control group ( P<0.05). There were no significant differences in hospital stay, ulcer healing rate and recurrence rate between two groups ( P>0.05). No deep venous thrombosis was found after treatment in two groups. The occurrence rates of skin burns and subcutaneous ecchymosis were significantly lower in the experimental group than those in the control group ( P<0.05). There were no significant differences in the incidence rates of other complications between two groups (P>0.05). Conclusion EVLA combined with PCCS in the treatment of severe saphenous varicose veins can significantly shorten the operation time, reduce the amount of bleeding, reduce the incidence rates of skin burns and subcutaneous ecchymosis on the premise of promising cure rate and recurrence rate. Overall, the combination therapy is superior than monotherapy.
